bioAffinity to present CyPath Lung data at NAVREF 2026 conference
bioAffinity Technologies says it will present two posters on its noninvasive lung cancer diagnostic CyPath® Lung at the NAVREF 2026 Annual Conference.
bioAffinity Technologies says it will present two posters on its noninvasive lung cancer diagnostic CyPath® Lung at the NAVREF 2026 Annual Conference.